financetom
Business
financetom
/
Business
/
Atlassian Gets 'In Process' FedRAMP Status
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Atlassian Gets 'In Process' FedRAMP Status
Jul 16, 2024 7:00 AM

09:40 AM EDT, 07/16/2024 (MT Newswires) -- Atlassian ( TEAM ) said Tuesday it has obtained an "In Process" status with the US Federal Risk and Authorization Management Program, or FedRAMP, and is now listed on the FedRAMP marketplace.

The company anticipates receiving the FedRAMP Moderate Authority to Operate for its Atlassian Government Cloud in Q1 next year, Atlassian ( TEAM ) said.

The Atlassian Government Cloud will provide automation and analytics for US federal agencies, and will include Jira, Confluence, and Jira Service Management, the company said.

Price: 181.09, Change: +1.14, Percent Change: +0.63

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-SLR Investment Acquires Factoring Business
BRIEF-SLR Investment Acquires Factoring Business
Oct 1, 2024
Sept 30 (Reuters) - SLR Investment Corp ( SLRC ): * SLR INVESTMENT CORP. ( SLRC ) ANNOUNCES ACQUISITION OF FACTORING BUSINESS * SLR INVESTMENT CORP ( SLRC ) - BUSINESS CREDIT ACQUIRES $115 MILLION DIVERSIFIED PORTFOLIO Source text for Eikon: Further company coverage: ...
Organon, Henlius Say Phase 3 Trial of Perjeta Biosimilar Meets Primary Endpoint
Organon, Henlius Say Phase 3 Trial of Perjeta Biosimilar Meets Primary Endpoint
Oct 1, 2024
08:31 AM EDT, 09/30/2024 (MT Newswires) -- Organon (OGN) and Shanghai Henlius Biotech said Monday the phase 3 trial of investigational Perjeta biosimilar HLX11 met its primary endpoint of total pathological complete response. The study compared the efficacy of HLX11 with Perjeta, or pertuzumab, in locally advanced breast cancer, the companies said. Secondary endpoints are currently being analyzed. Henlius agreed...
Brainsway Secures $20 Million Equity Financing From Valor Equity Partners
Brainsway Secures $20 Million Equity Financing From Valor Equity Partners
Oct 1, 2024
08:30 AM EDT, 09/30/2024 (MT Newswires) -- Brainsway ( BWAY ) shares jumped over 17% in recent Monday premarket activity after the company said it has entered into a $20 million securities purchase agreement with Valor Equity Partners affiliate in a private investment financing deal. As part of the deal, BrainsWay ( BWAY ) will issue 2.1 million American depositary...
Saputo Family Members and CDPQ Purchase 40 Million Common Shares
Saputo Family Members and CDPQ Purchase 40 Million Common Shares
Oct 1, 2024
08:31 AM EDT, 09/30/2024 (MT Newswires) -- Saputo (SAP.TO) on Monday said that Emanuele Saputo has increased his stake in the company from 32.5% to 38.7%. The dairy company announced that Jolina Capital, controlled by Emanuele Saputo, Emanuele Saputo, members of the Saputo family and an affiliate of fund manager Caisse de depot et placement du Quebec (CDPQ) together purchased...
Copyright 2023-2026 - www.financetom.com All Rights Reserved